Srinivas M, Singh Pathania Anup, Mahajan Priya, Verma Praveen K, Chobe Santosh S, Malik Fayaz A, Nargotra Amit, Vishwakarma Ram A, Sawant Sanghapal D
Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180 001, India; Academy of Scientific and Innovative Research, Anusandhan Bhawan, 2 Rafi Marg, New Delhi 110 001, India.
Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180 001, India; Academy of Scientific and Innovative Research, Anusandhan Bhawan, 2 Rafi Marg, New Delhi 110 001, India.
Bioorg Med Chem Lett. 2018 Apr 1;28(6):1005-1010. doi: 10.1016/j.bmcl.2018.02.032. Epub 2018 Feb 16.
A strategy for construction of medicinally important 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones has been devised and presented here. The compounds have been synthesized using one-pot multicomponent strategy under microwave assisted conditions. Triazolyl-quinazolinone based D-ring modified analogs are designed based on IC87114 scaffold, which is first known isoform selective inhibitor of PI3Kδ. Herein, we identified two triazolyl-quinazolinone compounds (5a and 5l) based on same scaffold with PI3Kγ specific inhibitory potential, the selectivity towards this isoform is well supported by in silico results, wherein, these compounds show better interaction and affinity and inhibitory activity for PI3Kγ rather than PI3Kδ. This repositioning of scaffold from PI3Kδ to PI3Kγ isoform can be very useful from medicinal chemistry and drug discovery perspective to unravel molecular interactions of this new scaffold in different cellular pathways.
本文设计并展示了一种构建具有重要药用价值的1,4-取代-1H-1,2,3-三唑并喹唑啉-4(3H)-酮的策略。这些化合物是在微波辅助条件下采用一锅多组分策略合成的。基于IC87114支架设计了基于三唑基喹唑啉酮的D环修饰类似物,IC87114是首个已知的PI3Kδ亚型选择性抑制剂。在此,我们鉴定了两种基于相同支架且具有PI3Kγ特异性抑制潜力的三唑基喹唑啉酮化合物(5a和5l),计算机模拟结果充分支持了对该亚型的选择性,其中,这些化合物对PI3Kγ表现出比PI3Kδ更好的相互作用、亲和力和抑制活性。从药物化学和药物发现的角度来看,将支架从PI3Kδ重新定位到PI3Kγ亚型对于揭示这种新支架在不同细胞途径中的分子相互作用可能非常有用。